fig1

COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium

Figure 1. Distribution of respondents to the survey and their affiliations to IRDiRC Constituent and Scientific Committees. The response rate from the Patient Advocates Constituent Committee (PACC, 63%), Funders Constituent Committee (FCC, 59%), and Therapies Scientific Committee (TSC, 58%) were the highest, with an overall participation rate of 46%. IRDiRC: International Rare Diseases Research Consortium.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/